Favipiravir 'very effective' against COVID-19, clinical trials show

A medicine called "Favipiravir" has been tested "very effective" against the world-sweeping COVID-19 caused by novel coronavirus, an official from China's sci-tech department in Beijing announced on Tuesday.

"A clinical trial was conducted in Shenzhen, which involves 80 patients," said Zhang Xinmin, head of China National Center for Biotech Development.

The medicine can shorten the recovery time from 11 days to four days for mild and regular cases, the trial showed.

Click here for more